speb/financial-data huggingface dataset:
CBZ cash_flow (quarterly, 2025-03-31) — Change In Receivables: -201258000.00
CBZ cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 45626000.00
CBZ cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -247717000.00
CBZ cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -201258000.00
CBZ cash_flow (quarterly, 2025-03-31) — Changes In Cash: -37864000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Common Stock: 1420000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1914701000.00
CBZ cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -7555000.00
CBZ income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 609912000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 87874000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Current Assets: 1002832000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 61673000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Current Debt: 66226000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 127899000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 660063000.00
CBZ cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 5639000.00
CBZ cash_flow (quarterly, 2025-03-31) — Deferred Tax: 5639000.00
CBZ cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 24791000.00
CBZ cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 24791000.00
CBZ income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 64279058.00
CBZ income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.91
CBZ income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 122773000.00
CBZ income_statement (quarterly, 2025-03-31) — EBIT: 198066000.00
CBZ income_statement (quarterly, 2025-03-31) — EBITDA: 222857000.00
CBZ cash_flow (quarterly, 2025-03-31) — End Cash Position: 149306000.00
CBZ cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 55363000.00
CBZ cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -93443000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -16000.00
CBZ income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 28070000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2906525000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Gross PPE: 474143000.00
CBZ income_statement (quarterly, 2025-03-31) — Gross Profit: 228102000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 42388000.00
CBZ income_statement (quarterly, 2025-03-31) — Interest Expense: 25156000.00
CBZ income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 25156000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3443431000.00
CBZ cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -4961000.00
CBZ cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 485600000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 360140000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1462504000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1822644000.00
CBZ cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 485600000.00
CBZ cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -358100000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 289000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -7555000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Net Debt: 1519880000.00
CBZ income_statement (quarterly, 2025-03-31) — Net Income: 122773000.00
CBZ income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 122773000.00
CBZ income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 122773000.00
CBZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 122773000.00
CBZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 122773000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 122773000.00
CBZ income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 122773000.00
CBZ income_statement (quarterly, 2025-03-31) — Net Interest Income: -25156000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 110000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 127500000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 127500000.00
CBZ income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -25156000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -64582000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -183000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Net PPE: 474143000.00
CBZ cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5177000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -991824000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 162066000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 163088000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1022000.00
CBZ income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 222857000.00
CBZ income_statement (quarterly, 2025-03-31) — Normalized Income: 122773000.00
CBZ cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -88266000.00
CBZ income_statement (quarterly, 2025-03-31) — Operating Income: 200032000.00
CBZ income_statement (quarterly, 2025-03-31) — Operating Revenue: 838014000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 54089000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 76847000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 66226000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 299256000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -16000.00
CBZ income_statement (quarterly, 2025-03-31) — Other Gand A: 28070000.00
CBZ income_statement (quarterly, 2025-03-31) — Other Income Expense: -1966000.00
CBZ cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1511000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 39932000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 22464000.00
CBZ income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -1966000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Other Properties: 474143000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Other Receivables: 290448000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Payables: 145034000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 232908000.00
CBZ income_statement (quarterly, 2025-03-31) — Pretax Income: 172910000.00
CBZ cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
CBZ cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -8300000.00
CBZ cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -5177000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Receivables: 735426000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -43629000.00
CBZ income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 609912000.00
CBZ income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 24791000.00
CBZ cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -358100000.00
CBZ cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -7555000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 181709000.00
CBZ income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
CBZ balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1018895000.00
CBZ cash_flow (quarterly, 2025-03-31) — Sale Of Business: 289000.00
CBZ cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 8410000.00
CBZ income_statement (quarterly, 2025-03-31) — Selling General And Administration: 28070000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Share Issued: 141924000.00
CBZ income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CBZ cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 4320000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1914701000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -991824000.00
CBZ income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CBZ income_statement (quarterly, 2025-03-31) — Tax Provision: 50137000.00
CBZ income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
CBZ balance_sheet (quarterly, 2025-03-31) — Total Assets: 4585498000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3377205000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Total Debt: 1950543000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1914701000.00
CBZ income_statement (quarterly, 2025-03-31) — Total Expenses: 637982000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2670797000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3582666000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2010734000.00
CBZ income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 200032000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 42388000.00
CBZ income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
CBZ income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CBZ balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 2538000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 87835000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 918327000.00
CBZ balance_sheet (quarterly, 2025-03-31) — Working Capital: 342769000.00
CBZ income_statement (quarterly, 2025-06-30) — +Operating Expense: 27637000.00
CBZ income_statement (quarterly, 2025-06-30) — +Total Revenue: 683496000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 119339000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 502115000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1821388000.00
CBZ cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 1445000.00
CBZ income_statement (quarterly, 2025-06-30) — Basic Average Shares: 63542000.00
CBZ income_statement (quarterly, 2025-06-30) — Basic EPS: 0.66
CBZ cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 149306000.00
CBZ cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -7948000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 407822000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1429000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 39817000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 39817000.00
CBZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -88612000.00
CBZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -7338000.00
CBZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 113146000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 16863000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 9081000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -17507000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -3469000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -40514000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Payable: -644000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 8437000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Receivables: 58151000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -17507000.00
CBZ cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 22605000.00
CBZ cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 58151000.00
CBZ cash_flow (quarterly, 2025-06-30) — Changes In Cash: 17196000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Common Stock: 1429000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1891843000.00
CBZ cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -71524000.00
CBZ income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 595587000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 106612000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Current Assets: 966035000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 62187000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Current Debt: 66274000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 128461000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 602321000.00
CBZ cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 11509000.00
CBZ cash_flow (quarterly, 2025-06-30) — Deferred Tax: 11509000.00
CBZ cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 25067000.00
CBZ cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 25067000.00
CBZ income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 63784000.00
CBZ income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.66
CBZ income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 41942000.00
CBZ income_statement (quarterly, 2025-06-30) — EBIT: 85646000.00
CBZ income_statement (quarterly, 2025-06-30) — EBITDA: 110713000.00
CBZ cash_flow (quarterly, 2025-06-30) — End Cash Position: 166502000.00
CBZ cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -88612000.00
CBZ cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 105198000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2131000.00
CBZ income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 27637000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2899958000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Gross PPE: 456011000.00
CBZ income_statement (quarterly, 2025-06-30) — Gross Profit: 87909000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 23892000.00
CBZ income_statement (quarterly, 2025-06-30) — Interest Expense: 27867000.00
CBZ income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 27867000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3446332000.00
CBZ cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -7338000.00
CBZ cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 364000000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 345635000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1488215000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1833850000.00
CBZ cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 364000000.00
CBZ cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -338700000.00
CBZ cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CBZ cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -71524000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Net Debt: 1514672000.00
CBZ income_statement (quarterly, 2025-06-30) — Net Income: 41942000.00
CBZ income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 41942000.00
CBZ income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 41942000.00
CBZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 41942000.00
CBZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 41942000.00
CBZ cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 41942000.00
CBZ income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 41942000.00
CBZ income_statement (quarterly, 2025-06-30) — Net Interest Income: -27867000.00
CBZ cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 2185000.00
CBZ cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 25300000.00
CBZ cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 25300000.00
CBZ income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -27867000.00
CBZ cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -41405000.00
CBZ cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -1575000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Net PPE: 456011000.00
CBZ cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -7948000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -1008115000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 177150000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 190304000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 13154000.00
CBZ income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 110713000.00
CBZ income_statement (quarterly, 2025-06-30) — Normalized Income: 41942000.00
CBZ cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 113146000.00
CBZ income_statement (quarterly, 2025-06-30) — Operating Income: 60272000.00
CBZ income_statement (quarterly, 2025-06-30) — Operating Revenue: 683496000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 54024000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 82142000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 66274000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 224017000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2131000.00
CBZ income_statement (quarterly, 2025-06-30) — Other Gand A: 27637000.00
CBZ income_statement (quarterly, 2025-06-30) — Other Income Expense: 25374000.00
CBZ cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2659000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 38819000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 17060000.00
CBZ income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 25374000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Other Properties: 456011000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Other Receivables: 223856000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Payables: 143231000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 249843000.00
CBZ income_statement (quarterly, 2025-06-30) — Pretax Income: 57779000.00
CBZ cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CBZ cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -11050000.00
CBZ cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -7948000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Receivables: 676054000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -49917000.00
CBZ income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 595587000.00
CBZ income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 25067000.00
CBZ cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -338700000.00
CBZ cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -71524000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 168022000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1060837000.00
CBZ cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
CBZ cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 13235000.00
CBZ income_statement (quarterly, 2025-06-30) — Selling General And Administration: 27637000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Share Issued: 142851000.00
CBZ cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7919000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1891843000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -1008115000.00
CBZ income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CBZ income_statement (quarterly, 2025-06-30) — Tax Provision: 15837000.00
CBZ income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
CBZ balance_sheet (quarterly, 2025-06-30) — Total Assets: 4537973000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3380058000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Total Debt: 1962311000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1891843000.00
CBZ income_statement (quarterly, 2025-06-30) — Total Expenses: 623224000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2646130000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 3571938000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2043809000.00
CBZ income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 60272000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 23892000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 2595000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 88827000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 989680000.00
CBZ balance_sheet (quarterly, 2025-06-30) — Working Capital: 363714000.00
CBZ income_statement (quarterly, 2025-09-30) — +Operating Expense: 31265000.00
CBZ income_statement (quarterly, 2025-09-30) — +Total Revenue: 693818000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 99653000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 471792000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1828903000.00
CBZ cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 1354000.00
CBZ income_statement (quarterly, 2025-09-30) — Basic Average Shares: 54104000.00
CBZ income_statement (quarterly, 2025-09-30) — Basic EPS: 0.56
CBZ cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 166502000.00
CBZ cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1910000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 386424000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1438000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 16969000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 16969000.00
CBZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -41984000.00
CBZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -4614000.00
CBZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 23966000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -19686000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 41599000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 18245000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -18612000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -10704000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Payable: -1441000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 40158000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Receivables: -43777000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 18245000.00
CBZ cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -32935000.00
CBZ cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -43777000.00
CBZ cash_flow (quarterly, 2025-09-30) — Changes In Cash: -22632000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Common Stock: 1438000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1871799000.00
CBZ cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -56472000.00
CBZ income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 603689000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 149367000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Current Assets: 1005415000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 64183000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Current Debt: 66323000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 130506000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 641759000.00
CBZ cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -8333000.00
CBZ cash_flow (quarterly, 2025-09-30) — Deferred Tax: -8333000.00
CBZ cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 24455000.00
CBZ cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 24455000.00
CBZ income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 62699000.00
CBZ income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.48
CBZ income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 30146000.00
CBZ income_statement (quarterly, 2025-09-30) — EBIT: 68366000.00
CBZ income_statement (quarterly, 2025-09-30) — EBITDA: 92821000.00
CBZ cash_flow (quarterly, 2025-09-30) — End Cash Position: 143870000.00
CBZ cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -41984000.00
CBZ cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 22056000.00
CBZ income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 1124000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -3373000.00
CBZ income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 31265000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2885727000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Gross PPE: 432831000.00
CBZ income_statement (quarterly, 2025-09-30) — Gross Profit: 90129000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 41712000.00
CBZ income_statement (quarterly, 2025-09-30) — Interest Expense: 27960000.00
CBZ income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 27960000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3440761000.00
CBZ cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -4614000.00
CBZ cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 343800000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 322241000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1502639000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1824880000.00
CBZ cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 343800000.00
CBZ cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -330700000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 1124000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -56472000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Net Debt: 1551993000.00
CBZ income_statement (quarterly, 2025-09-30) — Net Income: 30146000.00
CBZ income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 30146000.00
CBZ income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 30146000.00
CBZ income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 30146000.00
CBZ income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 30146000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 30146000.00
CBZ income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 30146000.00
CBZ income_statement (quarterly, 2025-09-30) — Net Interest Income: -27960000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -6250000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 13100000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 13100000.00
CBZ income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -27960000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 405000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 2422000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Net PPE: 432831000.00
CBZ cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1910000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1013928000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 181127000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 186317000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 5190000.00
CBZ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 91197000.00
CBZ income_statement (quarterly, 2025-09-30) — Normalized Income: 28934496.00
CBZ cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 23966000.00
CBZ income_statement (quarterly, 2025-09-30) — Operating Income: 58864000.00
CBZ income_statement (quarterly, 2025-09-30) — Operating Revenue: 693818000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 54104000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 96655000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 66323000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 220521000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -3373000.00
CBZ income_statement (quarterly, 2025-09-30) — Other Gand A: 31265000.00
CBZ income_statement (quarterly, 2025-09-30) — Other Income Expense: 9502000.00
CBZ cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3070000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 40044000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 17428000.00
CBZ income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 7878000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Other Properties: 432831000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Other Receivables: 300936000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Payables: 141365000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 290732000.00
CBZ income_statement (quarterly, 2025-09-30) — Pretax Income: 40406000.00
CBZ cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CBZ cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -16250000.00
CBZ cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1910000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Receivables: 719554000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -53174000.00
CBZ income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 603689000.00
CBZ income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 24455000.00
CBZ cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -330700000.00
CBZ cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -56472000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 172237000.00
CBZ income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: -500000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1090983000.00
CBZ cash_flow (quarterly, 2025-09-30) — Sale Of Business: 1124000.00
CBZ cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 10000000.00
CBZ income_statement (quarterly, 2025-09-30) — Selling General And Administration: 31265000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Share Issued: 143757000.00
CBZ income_statement (quarterly, 2025-09-30) — Special Income Charges: 1624000.00
CBZ cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7333000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1871799000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -1013928000.00
CBZ income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 412496.00
CBZ income_statement (quarterly, 2025-09-30) — Tax Provision: 10260000.00
CBZ income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
CBZ balance_sheet (quarterly, 2025-09-30) — Total Assets: 4545144000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3374438000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Total Debt: 1955386000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1871799000.00
CBZ income_statement (quarterly, 2025-09-30) — Total Expenses: 634954000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2673345000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3539729000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2031586000.00
CBZ income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 58864000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 41712000.00
CBZ income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1624000.00
CBZ income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1624000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 2961000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 89653000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 1046152000.00
CBZ balance_sheet (quarterly, 2025-09-30) — Working Capital: 363656000.00
CBZ income_statement (annual, 2025-12-31) — +Operating Expense: 121383000.00
CBZ income_statement (quarterly, 2025-12-31) — +Operating Expense: 34411000.00
CBZ income_statement (annual, 2025-12-31) — +Total Revenue: 2757991000.00
CBZ income_statement (quarterly, 2025-12-31) — +Total Revenue: 542663000.00
CBZ balance_sheet (annual, 2025-12-31) — Accounts Payable: 90934000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 90934000.00
CBZ balance_sheet (annual, 2025-12-31) — Accounts Receivable: 469209000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 469209000.00
CBZ balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -130286000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -130286000.00
CBZ balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1830866000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1830866000.00
CBZ cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 7290000.00
CBZ cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 4074000.00
CBZ income_statement (annual, 2025-12-31) — Basic Average Shares: 54380000.00
CBZ income_statement (quarterly, 2025-12-31) — Basic Average Shares: 54380000.00
CBZ income_statement (annual, 2025-12-31) — Basic EPS: 2.12
CBZ income_statement (quarterly, 2025-12-31) — Basic EPS: -1.46
CBZ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 187170000.00
CBZ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 143870000.00
CBZ balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 82579000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 82579000.00
CBZ cash_flow (annual, 2025-12-31) — Capital Expenditure: -16959000.00
CBZ cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1924000.00
CBZ balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 372579000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 372579000.00
CBZ balance_sheet (annual, 2025-12-31) — Capital Stock: 1447000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1447000.00
CBZ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 18290000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 18290000.00
CBZ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 18290000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 18290000.00
CBZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -145712000.00
CBZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -70479000.00
CBZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -15853000.00
CBZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1060000.00
CBZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 192485000.00
CBZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 143639000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Account Payable: 443000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -8719000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 14202000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 48164000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 17148000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -29216000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -22936000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 8135000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -53404000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 8252000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Payable: 17591000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Payable: -37935000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 31793000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 10229000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Receivables: -27096000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Receivables: 159788000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Tax Payable: 17148000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -29216000.00
CBZ cash_flow (annual, 2025-12-31) — Change In Working Capital: -71643000.00
CBZ cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 186404000.00
CBZ cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -27096000.00
CBZ cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 159788000.00
CBZ cash_flow (annual, 2025-12-31) — Changes In Cash: 30920000.00
CBZ cash_flow (quarterly, 2025-12-31) — Changes In Cash: 74220000.00
CBZ balance_sheet (annual, 2025-12-31) — Common Stock: 1447000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Common Stock: 1447000.00
CBZ balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1762067000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1762067000.00
CBZ cash_flow (annual, 2025-12-31) — Common Stock Payments: -167920000.00
CBZ cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -32369000.00
CBZ income_statement (annual, 2025-12-31) — Cost Of Revenue: 2402598000.00
CBZ income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 593410000.00
CBZ balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 197534000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 197534000.00
CBZ balance_sheet (annual, 2025-12-31) — Current Assets: 899249000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Current Assets: 899249000.00
CBZ balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 64674000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 64674000.00
CBZ balance_sheet (annual, 2025-12-31) — Current Debt: 66372000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Current Debt: 66372000.00
CBZ balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 131046000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 131046000.00
CBZ balance_sheet (annual, 2025-12-31) — Current Liabilities: 735594000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 735594000.00
CBZ cash_flow (annual, 2025-12-31) — Deferred Income Tax: 4632000.00
CBZ cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -4183000.00
CBZ cash_flow (annual, 2025-12-31) — Deferred Tax: 4632000.00
CBZ cash_flow (quarterly, 2025-12-31) — Deferred Tax: -4183000.00
CBZ cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 98270000.00
CBZ cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 23957000.00
CBZ cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 98270000.00
CBZ cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 23957000.00
CBZ income_statement (annual, 2025-12-31) — Diluted Average Shares: 63240000.00
CBZ income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 61917000.00
CBZ income_statement (annual, 2025-12-31) — Diluted EPS: 1.83
CBZ income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.46
CBZ income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 115444000.00
CBZ income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -79417000.00
CBZ income_statement (annual, 2025-12-31) — EBIT: 268050000.00
CBZ income_statement (quarterly, 2025-12-31) — EBIT: -84028000.00
CBZ income_statement (annual, 2025-12-31) — EBITDA: 366320000.00
CBZ income_statement (quarterly, 2025-12-31) — EBITDA: -60071000.00
CBZ cash_flow (annual, 2025-12-31) — End Cash Position: 218090000.00
CBZ cash_flow (quarterly, 2025-12-31) — End Cash Position: 218090000.00
CBZ cash_flow (annual, 2025-12-31) — Financing Cash Flow: -145712000.00
CBZ cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -70479000.00
CBZ cash_flow (annual, 2025-12-31) — Free Cash Flow: 175526000.00
CBZ cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 141715000.00
CBZ cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -711000.00
CBZ cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 413000.00
CBZ income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 711000.00
CBZ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: -413000.00
CBZ balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3291000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3291000.00
CBZ income_statement (annual, 2025-12-31) — General And Administrative Expense: 121383000.00
CBZ income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 34411000.00
CBZ balance_sheet (annual, 2025-12-31) — Goodwill: 2329799000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Goodwill: 2329799000.00
CBZ balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2869790000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2869790000.00
CBZ balance_sheet (annual, 2025-12-31) — Gross PPE: 545576000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Gross PPE: 545576000.00
CBZ income_statement (annual, 2025-12-31) — Gross Profit: 355393000.00
CBZ income_statement (quarterly, 2025-12-31) — Gross Profit: -50747000.00
CBZ cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 23577000.00
CBZ balance_sheet (annual, 2025-12-31) — Income Tax Payable: 11008000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 11008000.00
CBZ income_statement (annual, 2025-12-31) — Interest Expense: 107215000.00
CBZ income_statement (quarterly, 2025-12-31) — Interest Expense: 26232000.00
CBZ income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 107215000.00
CBZ income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 26232000.00
CBZ cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 105429000.00
CBZ balance_sheet (annual, 2025-12-31) — Invested Capital: 3217991000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3217991000.00
CBZ cash_flow (annual, 2025-12-31) — Investing Cash Flow: -15853000.00
CBZ cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 1060000.00
CBZ cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1480100000.00
CBZ cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 286700000.00
CBZ balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 307905000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 307905000.00
CBZ balance_sheet (annual, 2025-12-31) — Long Term Debt: 1389552000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1389552000.00
CBZ balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1697457000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1697457000.00
CBZ cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1480100000.00
CBZ cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 286700000.00
CBZ cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1428600000.00
CBZ cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -401100000.00
CBZ balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 77474000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 77474000.00
CBZ cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -1625000.00
CBZ cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -3038000.00
CBZ cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -167920000.00
CBZ cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -32369000.00
CBZ balance_sheet (annual, 2025-12-31) — Net Debt: 1437634000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Net Debt: 1437634000.00
CBZ income_statement (annual, 2025-12-31) — Net Income: 115444000.00
CBZ income_statement (quarterly, 2025-12-31) — Net Income: -79417000.00
CBZ income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 115444000.00
CBZ income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -79417000.00
CBZ income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 115444000.00
CBZ income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -79417000.00
CBZ income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 115444000.00
CBZ income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -79417000.00
CBZ income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 115444000.00
CBZ income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -79417000.00
CBZ cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 115444000.00
CBZ cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -79417000.00
CBZ income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 115444000.00
CBZ income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -79417000.00
CBZ income_statement (annual, 2025-12-31) — Net Interest Income: -107215000.00
CBZ income_statement (quarterly, 2025-12-31) — Net Interest Income: -26232000.00
CBZ cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -3684000.00
CBZ cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 271000.00
CBZ cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 51500000.00
CBZ cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -114400000.00
CBZ cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 51500000.00
CBZ cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -114400000.00
CBZ income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -107215000.00
CBZ income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -26232000.00
CBZ cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -29292000.00
CBZ cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 76290000.00
CBZ cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 6415000.00